The store will not work correctly when cookies are disabled.
4-(pyrrolidin-1-yl)-1-(3-(2-(pyrrolidin-1-yl)ethyl)phenyl)piperidine
ID: ALA3134135
Chembl Id: CHEMBL3134135
PubChem CID: 76318508
Max Phase: Preclinical
Molecular Formula: C21H33N3
Molecular Weight: 327.52
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: c1cc(CCN2CCCC2)cc(N2CCC(N3CCCC3)CC2)c1
Standard InChI: InChI=1S/C21H33N3/c1-2-12-22(11-1)15-8-19-6-5-7-21(18-19)24-16-9-20(10-17-24)23-13-3-4-14-23/h5-7,18,20H,1-4,8-17H2
Standard InChI Key: XXCKYCGUYJJDNV-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Calculated Properties
| Molecular Weight: 327.52 | Molecular Weight (Monoisotopic): 327.2674 | AlogP: 3.39 | #Rotatable Bonds: 5 |
| Polar Surface Area: 9.72 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
| #RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 10.22 | CX LogP: 3.15 | CX LogD: -1.66 |
| Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.82 | Np Likeness Score: -1.17 |
References
| 1. Camerino MA, Zhong N, Dong A, Dickson BM, James LI, Baughman BM, Norris JL, Kireev DB, Janzen WP, Arrowsmith CH, Frye SV.. (2013) The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface., 4 (11): [PMID:24466405] [10.1039/c3md00197k] |
